Mar. 8, 2026
Rhenman & Partners Asset Management AB Boosts Boston Scientific Holdings
Institutional investor increases stake in medical device company by 48% in Q3
Mar. 6, 2026
Dimensional Fund Advisors Increases Vertex Pharmaceuticals Stake
Institutional investor boosts holding in biotech firm by over 31%
Mar. 6, 2026
Quantbot Technologies LP Buys $1.46M Stake in Vertex Pharmaceuticals
The hedge fund added 3,727 shares of the biotech company in Q3 2025.
Mar. 5, 2026
ARK Investment Management Reduces Stake in DraftKings
Hedge fund cuts holdings in sports betting company by 23% in Q3
Mar. 4, 2026
Beta Bionics insider sells $13,151 in stock
Mike Mensinger, an insider at the medical device company, reduces his stake by 0.56%
Mar. 3, 2026
Ameresco (NYSE:AMRC) Stock Price Down 12.2%
Company reports Q4 beat but profitability concerns weigh on shares
Mar. 3, 2026
Relay Therapeutics Stock Price Rises 6%
Analysts Weigh In on Whether Investors Should Buy the Biotech Stock
Mar. 3, 2026
Victory Capital Management Boosts Stake in Vertex Pharmaceuticals
Institutional investor increases holding in pharmaceutical company by 4.3% in Q3
Mar. 3, 2026
Rafferty Asset Management Boosts Vertex Pharmaceuticals Stake
Institutional investor adds 6,020 shares to its Vertex Pharmaceuticals holdings
Mar. 3, 2026
Mitsubishi UFJ Asset Management Boosts Biogen Holdings
Institutional investor increases stake in biotech firm by 4.5% in Q3
Mar. 2, 2026
Royce & Associates Trims Stake in American Superconductor
Investment firm reduces holding in technology company by over 55%
Mar. 2, 2026
111 Capital Invests $1.71 Million in Vertex Pharmaceuticals
Pharmaceutical company sees large institutional investor take new position
Feb. 28, 2026
HC Wainwright Upgrades Edgewise Therapeutics to Strong Buy
Analysts see multiple near-term catalysts for the biotech company's pipeline
Feb. 28, 2026
Primecap Management Co. CA Increases Stake in Repligen Corporation
Biotechnology firm Repligen sees increased institutional investment in Q3 2026
Feb. 27, 2026
Beam Therapeutics Holds Great Potential, But Patience Needed
Biotech firm's base-editing gene therapy and pipeline show promise, but investors must exercise caution
Feb. 24, 2026
Billionaire Israel Englander Buys 2 Stocks That Can Soar 113% and 206%, According to Wall Street Analysts
Some Wall Street analysts expect Robinhood and Circle to deliver triple-digit returns in the next year.
Feb. 23, 2026
Investor Buys $81 Million in Praxis Stock as Shares Soar Over 300%
Baker Bros. Advisors LP significantly increased its stake in the biotech company as Praxis Precision Medicines advances late-stage CNS drug candidates.
Feb. 21, 2026
Can Oracle Stock Outpace The Giants?
How Oracle compares against key competitors in terms of size, valuation, and profitability.
Feb. 18, 2026
Vertex Pharmaceuticals Stock Gains in 2026 on Strong Fundamentals
Analysts remain moderately bullish on the biotech firm's growth prospects despite stock underperforming the broader market over the past year.
Feb. 10, 2026
Vertex Pharmaceuticals Reports Earnings on Feb. 12
Investors watch for updates on the launch of new cystic fibrosis drug Alyftrek and pain therapy Journavx
